Search results for: relievant

Need a new search

If you didn't find what you were looking for, try a new search!

Relievant announces publication of 5-Year data demonstrating long-term clinical benefits of the Intracept procedure in chronic low back pain patients

MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced European Spine Journal publication of long-term data from the Level I SMART trial showing durability of [...]

2023-04-12T13:30:05+01:00June 8th, 2020|

Relievant Announces Publication of Positive Results from Multi-Center Study of the Intracept® Procedure in Real-world Setting for Patients with Chronic Low Back Pain

MINNEAPOLIS – August 27, 2019 – Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the publication of significant and clinically-meaningful outcomes from a prospective, open-label, single-arm, multi-center study in the European [...]

2023-04-06T10:28:15+01:00August 27th, 2019|

Interview with Kevin Hykes, President & CEO at Relievant

Can you tell us a bit about Relievant Medsystems and the Intracept® Procedure? Relievant is a venture-backed medical device company founded in 2006, based in Minneapolis and Sunnydale, California with around 45 employees. Our focus is currently shifting from research and [...]

2023-05-08T09:06:53+01:00June 12th, 2019|

Relievant announces publication of SMART trial 24-month results

Intracept® Procedure Demonstrates Durable Results at 24 Months. MINNEAPOLIS – April 24, 2019 – Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced the publication of 24-month results from the SMART trial [...]

2023-04-03T16:04:54+01:00April 28th, 2019|
Go to Top